Cargando…

A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention

BACKGROUND: Percutaneous coronary intervention (PCI) is widely used in China, but it does not fundamentally improve exercise endurance or reduce mortality associated with cardiovascular disease. Standardized cardiac rehabilitation (CR) can reduce the mortality associated with coronary heart disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Linghua, Lu, Xiaoyan, Li, Xianlun, Jiang, Hong, Sun, Ruihua, Chen, Gang, Xiao, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407996/ https://www.ncbi.nlm.nih.gov/pubmed/34475964 http://dx.doi.org/10.1155/2021/7439852

Ejemplares similares

Qishen Yiqi dripping pills for ischemic heart failure: A protocol for a prospective cohort study
por: Zhao, Zhiqiang, et al.
Publicado: (2018)

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial
por: Mao, Jingyuan, et al.
Publicado: (2020)

The role of Qishen Yiqi dripping pills in treating chronic heart failure: An overview of systematic reviews and meta-analyses
por: Chen, Wensheng, et al.
Publicado: (2022)

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
por: Hou, Ya Zhu, et al.
Publicado: (2013)

Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats
por: Li, Shaohua, et al.
Publicado: (2022)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

Antiplatelet Effects of Qishen Yiqi Dropping Pill in Platelets Aggregation in Hyperlipidemic Rabbits
por: Wang, Yi, et al.
Publicado: (2012)

Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia
por: JianXin, Chen, et al.
Publicado: (2016)

Efficacy and safety of Qishen Yiqi dripping pills as a complementary treatment for Heart Failure: A protocol of updated systematic review and meta-analysis
por: Guan, Hui, et al.
Publicado: (2021)

Protective effect of Qishen Yiqi dropping pills on the myocardium of rats with chronic heart failure
por: Lu, Yinghong, et al.
Publicado: (2019)

Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies
por: Wang, Hao, et al.
Publicado: (2020)

Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
por: Zhang, Qian, et al.
Publicado: (2021)

Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-Induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis
por: Wang, Lijiang, et al.
Publicado: (2019)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
por: Li, Meng, et al.
Publicado: (2022)

Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
por: Luo, Ying, et al.
Publicado: (2022)

The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis
por: Zheng, Shichao, et al.
Publicado: (2015)

The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
por: Li, Cailan, et al.
Publicado: (2020)

Qishen Yiqi dropping pills improve cardiomyocyte hypertrophy via the lncRNA TINCR/miR-193b-3p/RORA axis
por: Chen, Lei, et al.
Publicado: (2022)

Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose‐induced injury in cardiomyocytes
por: Zhang, Shouyan, et al.
Publicado: (2019)

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014)

Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Lisheng, et al.
Publicado: (2021)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
por: Nan, Lyu, et al.
Publicado: (2021)

Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study
por: Luo, Dan, et al.
Publicado: (2015)

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
por: Du, Kangjia, et al.
Publicado: (2022)

Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis
por: Sun, Ling, et al.
Publicado: (2022)

Recommendations on the Clinical Use of Compound Danshen Dripping Pills
Publicado: (2017)

Proangiogenesis effects of compound danshen dripping pills in zebrafish
por: Hu, Yang-Xi, et al.
Publicado: (2022)

The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline
por: Zhang, Miao, et al.
Publicado: (2022)

Network pharmacology-based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment
por: Li, Zheng, et al.
Publicado: (2021)

Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial
por: Tian, Pan-pan, et al.
Publicado: (2018)

Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction
por: Wang, Yangyun, et al.
Publicado: (2019)

Functional Evaluation of Percutaneous Coronary Intervention Based on CT Images of Three-Dimensional Reconstructed Coronary Artery Model
por: Fu, Dongliang, et al.
Publicado: (2023)

Compound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2018)

Metabonomic Strategy to the Evaluation of Chinese Medicine Compound Danshen Dripping Pills Interfering Myocardial Ischemia in Rats
por: Xin, Xue, et al.
Publicado: (2013)

Efficacy and Safety of Ginkgo Biloba Pills for Coronary Heart Disease with Impaired Glucose Regulation: Study Protocol for a Series of N-of-1 Randomized, Double-Blind, Placebo-Controlled Trials
por: Sun, Mingyue, et al.
Publicado: (2018)

A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials
por: Chen, Ruixue, et al.
Publicado: (2018)

Synergistic Effects of Clopidogrel and Fufang Danshen Dripping Pills by Modulation of the Metabolism Target and Pharmacokinetics
por: Ma, Shitang, et al.
Publicado: (2014)

Real-time quality control of dripping pill’s weight based on laser detection technology
por: Wang, Xiaoping, et al.
Publicado: (2023)

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Wei, Jingjing, et al.
Publicado: (2021)

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial
por: Ge, Jun-Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k8ien5jjdq9n61k05td3q2t9eh